首页> 外文会议>World biomaterials congress >Forming PCL-gelatin electrospun multiaxial fibers with tunable release of therapeutic agents
【24h】

Forming PCL-gelatin electrospun multiaxial fibers with tunable release of therapeutic agents

机译:形成可调节释放治疗剂的PCL明胶电纺多轴纤维

获取原文

摘要

Introduction: Novel developments in electrospinning allow formation of nano and micro size fibers with controllable functions such as altered surface (hydrophobic and hydrophilic) structures, and multi-layered structures. Structures with desirable properties can be developed by layering synthetic polymer to provide mechanical properties while natural polymer to promote cellular regulation. Primary caveat is limitation in suitable solvents that offer compatibility and high production rates. There is also a limited understanding of the influence of the compartment in which a drug is loaded. In this regard, we explored the formation of polycaprolactone (PCL) and gelatin multiaxial fibers either in combination using a common solvent along with various configurations of individual components. Doxycycline (Dox) an antibiotic and inhibitor of matrix degrading enzymes with short serum half-life was used as a model drug. We evaluated the fabrication of PCL/gelatin electrospun fibers to provide controlled release of Dox. Experimental Methods: We used a custom-built multi-axial electrospinning setup as described previously. PCL and gelatin were dissolved separately in TFE and solutions were mixed together when needed. We tested the effect of ⅰ) PCL/Gelatin ratio, ⅱ) flow rate and ⅲ) spinning distance. Fibers were characterized using SEM, TEM, DSC and FTIR were performed to determine the presence of components. Using the optimized setting, we formed multi-axial fibers with PCL-gelatin as the ⅰ) inner core and ⅱ) outer sheath. We tested forming fibers with gelatin, PCL and PCL/Gelatin as various configurations. Distribution and stability of gelatin was evaluated. Dox was loaded in various locations and release profiles were compared over five days. Alterations in fiber morphologies were evaluated by SEM. Cell culture studies were performed and inhibition of matrix metalloprotease-2/9 was evaluated. Results and Discussion: We successfully formed single/coaxial and triaxial fibers loaded Doxy. SEM images showed uniform fiber size distribution. Gelatin distribution in PC/Gelatin blend single and coaxial fibers was uniform. When fiber diameters were determined, PCL/Gelatin fibers formed at 1 ml/hr had 5.36 (±2.12) μm diameter (Figure 1 A), nearly double that formed at 0.5 ml/hr (Figure 1.B). Increasing the polymer concentration increased the fiber sizes. Loading Doxy in the spinning solution increased the fiber diameter. FT-IR and DSC revealed the presence of each component. TEM results showed presence of multiple layers but co-axial to have more uniform distribution (Figure 1.C). Presence of PCL/gelatin as the outer sheath produced more uniform fibers consistently than when it was present as the inner sheath. Also, Dox release studies were performed in fibers with PCL/gelatin combination as the outer sheath. Dox release studies showed differences based on the compartment in which they were loaded. Compared to single fibers where quick release was observed, co-axial fibers produced better release profiles. There were differences in release profiles when Dox was loaded in the inner PCL alone, gelatin alone or combination of PCI/gelatin. Also, triaxial fibers had large deviations, probably due to non-uniform distribution of fibers. Conclusion: We show that multilayered fibers with PCL and gelatin can be formed. They can be used for altering the release profile of therapeutic agents.
机译:简介:电纺的新进展允许形成具有可控功能的纳米和微米尺寸的纤维,例如改变的表面(疏水和亲水)结构和多层结构。具有理想性能的结构可通过将合成聚合物分层以提供机械性能而开发,而天然聚合物则可促进细胞调节。主要警告是在提供相容性和高生产率的合适溶剂中的局限性。对装有药物的隔室的影响的理解还很有限。在这方面,我们探索了聚己内酯(PCL)和明胶多轴纤维的形成,它们是使用常见的溶剂以及各个组件的各种配置组合而成的。强力霉素(Dox)是一种抗生素和具有血清半衰期短的基质降解酶抑制剂,被用作模型药物。我们评估了PCL /明胶电纺纤维的制造过程,以提供Dox的受控释放。实验方法:如前所述,我们使用了定制的多轴电纺装置。将PCL和明胶分别溶解在TFE中,并在需要时将溶液混合在一起。我们测试了ⅰ)PCL /明胶比,ⅱ)流量和ⅲ)旋转距离的影响。使用SEM,TEM,DSC和FTIR对纤维进行表征,以确定组分的存在。通过优化设置,我们形成了以PCL-明胶为ⅰ)内芯和ⅱ)外包皮的多轴纤维。我们测试了明胶,PCL和PCL /明胶作为各种配置的成型纤维。评价明胶的分布和稳定性。将Dox装载在各个位置,并比较了五天的释放曲​​线。通过SEM评估纤维形态的变化。进行细胞培养研究并评估基质金属蛋白酶-2/9的抑制作用。结果与讨论:我们成功地形成了负载Doxy的单/同轴和三轴纤维。 SEM图像显示均匀的纤维尺寸分布。 PC /明胶共混单根和同轴纤维中的明胶分布均匀。确定纤维直径后,以1 ml / hr形成的PCL /明胶纤维的直径为5.36(±2.12)μm(图1 A),几乎是以0.5 ml / hr形成的PCL /明胶纤维的两倍(图1.B)。增加聚合物浓度会增加纤维尺寸。在纺丝溶液中加入Doxy会增加纤维直径。 FT-IR和DSC揭示了每种成分的存在。 TEM结果显示存在多层,但同轴以具有更均匀的分布(图1.C)。与作为内鞘层存在的PCL /明胶相比,作为外鞘层存在的纤维始终如一地产生更均匀的纤维。同样,在以PCL /明胶组合为外鞘的纤维中进行了Dox释放研究。 Dox释放研究表明,根据装载它们的隔室的不同而有所差异。与观察到快速释放的单纤维相比,同轴纤维产生了更好的释放曲线。当Dox单独装在内部PCL,明胶单独或PCI /明胶组合中时,释放曲线有差异。而且,三轴纤维具有较大的偏差,这可能是由于纤维的不均匀分布所致。结论:我们表明可以形成具有PCL和明胶的多层纤维。它们可用于改变治疗剂的释放特性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号